Development of inactivated Akabane and bovine ephemeral fever vaccine for cattle.
10.14405/kjvr.2015.55.4.227
- Author:
Dong Kun YANG
1
;
Ha Hyun KIM
;
Hyun Ye JO
;
Sung Suk CHOI
;
In Soo CHO
Author Information
1. Viral disease division, Animal and Plant Quarantine Agency, Anyang 14089, Korea. yangdk@korea.kr
- Publication Type:Original Article
- Keywords:
Akabane virus;
bovine ephemeral fever;
cattle;
vaccine
- MeSH:
Animals;
Antibodies, Neutralizing;
Baculoviridae;
Cattle;
Cattle*;
Ephemeral Fever*;
Flagellin;
Guinea Pigs;
Mice;
Vaccines;
Vibrio
- From:Korean Journal of Veterinary Research
2015;55(4):227-232
- CountryRepublic of Korea
- Language:English
-
Abstract:
Akabane and bovine ephemeral fever (BEF) viruses cause vector-borne diseases. In this study, inactivated Akabane virus (AKAV)+Bovine ephemeral fever virus (BEFV) vaccines with or without recombinant vibrio flagellin (revibFlaB) protein were expressed in a baculovirus expression system to measure their safety and immunogenicity. Blood was collected from mice, guinea pigs, sows, and cattle that had been inoculated with the vaccine twice. Inactivated AKAV+BEFV vaccine induced high virus neutralizing antibody (VNA) titer against AKAV and BEFV in mice and guinea pigs. VNA titers against AKAV were higher in mice and guinea pigs immunized with the inactivated AKAV+ BEFV vaccine than in animals inoculated with vaccine containing revibFlaB protein. Inactivated AKAV+BEFV vaccine elicited slightly higher VNA titers against AKAV and BEFV than the live AKAV and live BEFV vaccines in mice and guinea pigs. In addition, the inactivated AKAV+BEFV vaccine was safe, and induced high VNA titers, ranging from 1 : 64 to 1 : 512, against both AKAV and BEFV in sows and cattle. Moreover, there were no side effects observed in any treated animals. These results indicate that the inactivated AKAV+BEFV vaccine could be used in cattle with high immunogenicity and good safety.
